Cancer Trials Australia (CTA) is a not-for-profit, member-based organisation consisting of 34 clinical sites and 3 research institutes, spanning all major Australian states as well as New Zealand.

CTA was formed in 1993 out of the Centre for Developmental Cancer Therapies (CDCT) by a small group of medical oncologists, who wanted to conduct clinical trials with cytokines developed by Professor Don Metcalf and his colleagues at the Walter and Eliza Hall Institute. In 2003, CTA was incorporated as a public company limited by guarantee (Not-For-Profit, member-based organisation), with our six founding members. Our original expertise in the field of oncology has expanded over the years to include other related disciplines (e.g. radiation oncology) and other therapeutic areas.

CTA continues to be actively involved in ongoing regulatory reform and changes across the Australian health sector, both at a Federal and State level. Our members are supported through CTA’s strong advocacy position with both Government and sector peak bodies.

More recently, with the support from the Department of Health Victoria via the Victorian Cancer Agency, CTA was pleased to take carriage of the Victorian Annual Cancer Clinical Trials Census. Previously developed and coordinated by the Cancer Council Victoria, this census is a valuable data set to understand cancer clinical trial participation across the state of Victoria and help inform future Government policy.